A high-molecular-weight form of insulin-like growth factor-2 (IGF-2), known as “big” IGF-2, is occasionally produced in various tumor types regardless of whether the origin is mesenchymal or epithelial, and can lead to hypoglycemia through insulin receptor (IR) signaling [1, 2]. The gene discussed is IGF2; the disease is Hypoglycemia.